Dec 21, 2023 8:30am EST RenovoRx Engages Oklahoma University (OU) Health as First Clinical Site in Preparation for the Pivotal Phase III CouGar Clinical Trial in Bile Duct Cancer
Dec 19, 2023 8:30am EST RenovoRx Announces Clinical Data Abstract at the 2024 Society of Interventional Radiology Annual Scientific Meeting
Dec 13, 2023 8:31am EST RenovoRx Files New International Patent for Novel Targeted Combination Drug-Delivery Oncology Therapy Platform
Nov 16, 2023 8:35am EST RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
Nov 14, 2023 8:30am EST RenovoRx Reports Third Quarter 2023 Financial Results and Operational Highlights
Oct 02, 2023 8:30am EDT RenovoRx to Present at the ROTH MKM Healthcare Opportunities Conference on October 12, 2023
Aug 17, 2023 8:30am EDT RenovoRx Reports Second Quarter 2023 Financial Results and Operational Highlights
Jul 20, 2023 8:00am EDT RenovoRx and Imugene Announce Collaboration to Deliver Oncolytic Virus Therapy Using Proprietary Trans-Arterial Micro-Perfusion (TAMP™) Platform
